FDA publishes a final guidance on its approach to enforcement involving animal drugs compounded from bulk drug substances.
Pro golfer James Hahn is partnering with IBSA Pharma to promote its Licart prescription topical NSAID.
FDA grants Safer Technologies Program designation for a Pear Therapeutics pain control device.
Aeglea BioTherapeutics files a BLA for pegzilarginase for treating Arginase 1 Deficiency.
FDA approves a Boston Scientific PMA for its latest image guided programming software, Vercise Neural Navigator with StimViewXT, for use in brain stim...
The International Council on Harmonization says three guidelines are at Stage 2 and open for public comment.
Some 30 House and Senate members ask CEOs of seven manufacturers of naloxone to seek OTC status for their drug.
FDA announces a 7/12-13 CDRH Patient Engagement Advisory Committee meeting that will discuss and make recommendations on augmented reality and virtual...